Carl Zeiss Meditec AG CARL ZEISS MEDITEC ORD SHS
Carl Zeiss Meditec AG CARL ZEISS .../ DE0005313704 /
0DHC
|
14/11/2024 18:31:32
|
Chg.
+0.17
|
Volume |
Bid14/11/2024 |
Ask14/11/2024 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
57.60EUR
|
+0.30%
|
21,256
Turnover: 1.25 mill. |
-Bid Size: - |
-Ask Size: - |
5.25 bill.EUR |
1.87% |
18.08 |
Business description
Carl Zeiss Meditec AG is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumable materials. The Company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of ZEISS is rounded off by promising future technologies such as intraoperative radiation therapy.
Management board & Supervisory board
| CEO |
| Dr. Markus Weber |
| Management board |
| Justus Felix Wehmer |
| Supervisory board |
| Dr. Karl Lamprecht, Isabel De Paoli, Tanja von der Goltz, Peter Kameritsch, Dr. Christian Müller, Torsten Reitze, Renè Denner, Brigitte Koblizek, Jeffrey Marx , Heike Madan, Falk Bindheim, Dr. Christian Münster |
Company data
| Name: |
Carl Zeiss Meditec AG |
| Address: |
Göschwitzer Straße 51-52,D-07745 Jena |
| Phone: |
+49-3641-220-0 |
| Fax: |
+49 3641 220 112 |
| E-mail: |
info@meditec.zeiss.com
|
| Internet: |
zeiss.de/corporate/home.html |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
30/09 |
| Free Float: |
40.90% |
| IPO date: |
22/03/2000 |
